Rocket Pharmaceuticals, Inc. (RCKT) stock
RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$1.95−0.16 (-7.58%)
Close on Nov 20, 2026Market cap $214.06MP/E –Yield –
Rocket Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Rocket Pharmaceuticals's pe ratio was 13.8× on Jan 31, 2018.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jan 31, 2018 | 13.8× | +6.2 |
| 2017 | Dec 29, 2017 | 7.6× | – |
See a number that looks wrong?